The Lightning Health team is delighted to announce Dr Frances Macdonald is joining the network as an executive advisor for European HTA.

Dr Macdonald brings a wealth of experience to the network. She was a member of the Scottish Medicines Consortium (SMC) for 7 years as the lead industry representative, sponsored by the Association of the British Pharmaceutical Industry (ABPI). She chaired the joint SMC/industry user group forum, ensuring industry input and collaboration on the evolution of SMC processes and methods.

Earlier in her career, Dr Macdonald spent 7 years leading European then Global Health Economic and Outcomes Research groups in Syntex (UK) followed by Roche (Basel). Within Roche, her team provided strategic advice plus operational support on health economics and pricing throughout the company, from basic research through to the commercial affiliates.

Dr Macdonald has also worked in a range of roles in clinical development, including Project Management, Clinical Pharmacology, and European Regulatory Affairs and led a Global Lifecycle team within the Roche oncology franchise. Frances also established and led the UK and Irish commercial subsidiary of Actelion as UK Managing Director. Dr Macdonald holds a PhD in Physiology from Glasgow University.

Her experience will be of tremendous value to our clients and we look forward to the collaboration.

Lightning Health are a digital led market access agency providing streamlined payer research programmes and market access consultancy to the life sciences industry.

Please visit www.lightning-api.com for more information or email jwhitehouse@lightning-api.com

The Lightning Health team


Article published 23 January 2019.